ARTHRITIS  DRUGS ADVISORY COMMITTEE

August 16, 2001

Kineret™ (anakinra)
(Recombinant Methionyl Human Interleukin-1 Receptor Antagonist)

Briefing Information

Amgen Inc

Disclaimer

The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Briefing Package   pdf   doc

Food and Drug Administration

Briefing Information   pdf   doc